Risk of venous thromboembolism in autoimmune diseases : A comprehensive review
Copyright © 2023. Published by Elsevier B.V..
Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of the disease, and to concomitant treatments. In this review, we revise the most common autoimmune disease such as antiphospholipid syndrome, inflammatory myositis, polymyositis and dermatomyositis, rheumatoid arthritis, sarcoidosis, Sjogren syndrome, autoimmune haemolytic anaemia, systemic lupus erythematosus, systemic sclerosis, vasculitis and inflammatory bowel disease. We also provide an overview of pathophysiology responsible for the risk of VTE in each autoimmune disorder, and report current indications to anticoagulant treatment for primary and secondary prevention of VTE.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Autoimmunity reviews - 22(2023), 11 vom: 14. Nov., Seite 103447 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Menichelli, Danilo [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.11.2023 Date Revised 03.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.autrev.2023.103447 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362115583 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362115583 | ||
| 003 | DE-627 | ||
| 005 | 20231226090547.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.autrev.2023.103447 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM362115583 | ||
| 035 | |a (NLM)37714419 | ||
| 035 | |a (PII)S1568-9972(23)00181-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Menichelli, Danilo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk of venous thromboembolism in autoimmune diseases |b A comprehensive review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.11.2023 | ||
| 500 | |a Date Revised 03.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier B.V. | ||
| 520 | |a Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of the disease, and to concomitant treatments. In this review, we revise the most common autoimmune disease such as antiphospholipid syndrome, inflammatory myositis, polymyositis and dermatomyositis, rheumatoid arthritis, sarcoidosis, Sjogren syndrome, autoimmune haemolytic anaemia, systemic lupus erythematosus, systemic sclerosis, vasculitis and inflammatory bowel disease. We also provide an overview of pathophysiology responsible for the risk of VTE in each autoimmune disorder, and report current indications to anticoagulant treatment for primary and secondary prevention of VTE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antiphospholipid syndrome | |
| 650 | 4 | |a Autoimmune haemolytic anaemia | |
| 650 | 4 | |a Inflammatory bowel disease | |
| 650 | 4 | |a Myositis | |
| 650 | 4 | |a Rheumatoid arthritis | |
| 650 | 4 | |a Sarcoidosis | |
| 650 | 4 | |a Sjogren syndrome | |
| 650 | 4 | |a Systemic lupus erythematosus | |
| 650 | 4 | |a Systemic sclerosis | |
| 650 | 4 | |a Vasculitis | |
| 650 | 4 | |a Venous thromboembolism | |
| 700 | 1 | |a Cormaci, Vito Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Marucci, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Franchino, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Del Sole, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Capozza, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Fallarino, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Valeriani, Emanuele |e verfasserin |4 aut | |
| 700 | 1 | |a Violi, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Pignatelli, Pasquale |e verfasserin |4 aut | |
| 700 | 1 | |a Pastori, Daniele |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Autoimmunity reviews |d 2002 |g 22(2023), 11 vom: 14. Nov., Seite 103447 |w (DE-627)NLM126096996 |x 1873-0183 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2023 |g number:11 |g day:14 |g month:11 |g pages:103447 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.autrev.2023.103447 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2023 |e 11 |b 14 |c 11 |h 103447 | ||